These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


226 related items for PubMed ID: 226105

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Serum lipoprotein composition in different types of hyperlipoproteinemia.
    Carlson LA.
    Adv Exp Med Biol; 1975; 63():185-99. PubMed ID: 173148
    [Abstract] [Full Text] [Related]

  • 9. The effect of D-thyroxine on lipoprotein lipids and apolipoproteins in primary type IIa hyperlipoproteinemia.
    Schwandt P, Weisweiler P.
    Atherosclerosis; 1980 Mar; 35(3):301-6. PubMed ID: 6987993
    [Abstract] [Full Text] [Related]

  • 10. Lipid lowering drugs and hyperlipidaemia.
    Levy RI, Rifking BM.
    Drugs; 1973 Mar; 6(1):12-45. PubMed ID: 4361281
    [No Abstract] [Full Text] [Related]

  • 11. Cholestyramine in type IIa hyperlipoproteinemia. Is low-dose treatment feasible?
    Angelin B, Einarsson K.
    Atherosclerosis; 1981 Mar; 38(1-2):33-8. PubMed ID: 7470203
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Lecithin: cholestrol acyl transfer rate and high density lipoproteins in plasma during dietary and cholestyramine treatment of type IIa hyperlipoproteinaemia.
    Wallentin L.
    Eur J Clin Invest; 1978 Dec; 8(6):383-9. PubMed ID: 217692
    [No Abstract] [Full Text] [Related]

  • 14. Serum lipoprotein lipids after gemfibrozil treatment.
    Schwandt P, Weisweiler P, Neureuther G.
    Artery; 1979 Feb; 5(2):117-24. PubMed ID: 231950
    [Abstract] [Full Text] [Related]

  • 15. [Effect of beta-pyridylcarbinol on lipids and lipoprotein in primary type IIa hyperlipoproteinemia].
    Hutt V, Wechsler JG, Klör HU, Ditschuneit H.
    Arzneimittelforschung; 1983 Feb; 33(12):1682-4. PubMed ID: 6686774
    [Abstract] [Full Text] [Related]

  • 16. Effect of dietary treatment on the lipid, lipoprotein and fatty acid compositions in type IV familial hypertriglyceridemia.
    Agheli N, Cloarec M, Jacotot B.
    Ann Nutr Metab; 1991 Feb; 35(5):261-73. PubMed ID: 1776822
    [Abstract] [Full Text] [Related]

  • 17. Concentration and composition of the lipoprotein classes in human umbilical cord serum.
    Winkler L, Schlag B, Goetze E.
    Clin Chim Acta; 1977 Apr 15; 76(2):187-91. PubMed ID: 193656
    [Abstract] [Full Text] [Related]

  • 18. [Hypolipidemic effect of cholestyramine in patients affected by type II hyperlipoproteinemia].
    Sauvanet JP, Drouin P, Mejean L, Lambert D, Debry G.
    Therapie; 1978 Apr 15; 33(5):615-22. PubMed ID: 217121
    [No Abstract] [Full Text] [Related]

  • 19. Protective effect of rutin on lipids, lipoproteins, lipid metabolizing enzymes and glycoproteins in streptozotocin-induced diabetic rats.
    Stanely Mainzen Prince P, Kannan NK.
    J Pharm Pharmacol; 2006 Oct 15; 58(10):1373-83. PubMed ID: 17034661
    [Abstract] [Full Text] [Related]

  • 20. Metabolic relationships among the plasma lipoproteins. Reciprocal changes in the concentrations of very low and low density lipoproteins in man.
    Wilson DE, Lees RS.
    J Clin Invest; 1972 May 15; 51(5):1051-7. PubMed ID: 4341500
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.